US Airways Is on a ...
Health Care: Drugs
Albany Molecular Research Inc. (AMRI: NASDAQ)
$10.95 0.04 | 0.37%
05/22/13 - 11:19 AM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 23.29M | 19.98M | 25.75M | 80.95M |
| Receivables | 50.68M | 40.66M | 47.82M | 30.72M |
| Inventories | 28.22M | 26.00M | 27.10M | 25.14M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 58.00K |
| Total Current Assets | 113.42M | 100.56M | 134.05M | 180.46M |
| Property, Plant & Equipment, Gross | 294.49M | 296.63M | 294.56M | 277.69M |
| Accumulated Depreciation & Depletion | 158.97M | 146.83M | 131.35M | 110.94M |
| Property, Plant & Equipment, Net | 135.52M | 149.80M | 163.21M | 166.75M |
| Intangibles | 3.06M | 2.98M | 3.94M | 2.46M |
| Other Non-Current Assets | 7.33M | 2.36M | 6.61M | 5.30M |
| Total Non-Current Assets | 149.44M | 162.51M | 191.06M | 193.23M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 262.86M | 263.07M | 325.11M | 373.69M |
| Accounts Payable | 18.19M | 20.42M | 24.72M | 15.28M |
| Short Term Debt | 776.00K | 2.84M | 1.48M | 270.00K |
| Other Current Liabilities | 11.64M | 4.08M | 9.80M | 1.10M |
| Total Current Liabilities | 35.99M | 37.98M | 54.64M | 30.73M |
| Long Term Debt | 7.23M | 3.00M | 11.74M | 13.21M |
| Deferred Income Taxes | 753.00K | 733.00K | 0.00 | 0.00 |
| Other Non-Current Liabilities | 12.76M | 14.92M | 14.99M | 15.13M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 20.74M | 18.66M | 26.73M | 28.34M |
| Total Liabilities | 56.72M | 56.63M | 81.36M | 59.08M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 206.14M | 206.43M | 243.74M | 314.61M |
| Common Par | 363.00K | 360.00K | 357.00K | 355.00K |
| Additional Paid In Capital | 207.78M | 206.07M | 203.96M | 201.67M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 75.18M | 78.95M | 111.25M | 174.12M |
| Treasury Stock | -66.89M | -66.89M | -66.89M | -56.89M |
| Other Equity Adjustments | -10.30M | -12.07M | -4.94M | -4.64M |
| Total Capitalization | 213.37M | 209.44M | 255.48M | 327.82M |
| Total Equity | 206.14M | 206.43M | 243.74M | 314.61M |
| Total Liabilities & Stock Equity | 262.86M | 263.07M | 325.11M | 373.69M |
| Total Common Shares Outstanding | 30.92M | 30.60M | 30.26M | 31.64M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 5.41M | 5.41M | 5.41M | 3.82M |
| Basic Weighted Shares Outstanding | 30.32M | 29.96M | 30.66M | 31.06M |
| Diluted Weighted Shares Outstanding | 30.32M | 29.96M | 30.66M | 31.06M |
| Number of Employees | 1329 | 1389 | 1421 | 1266 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AMRI
- Portfolio NameUser Type
- UserJoePa66
- UserPART 7 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserPART 7 JPMorgan 26th Annual...
- Userwafessler Portfolio 1
- UserSUPRATRADE SMALL CAP "...
- Userscorp Portfolio 1
- UserNew IDea
- Userctshagr Portfolio 1
- Useraaron81483 Portfolio 1
Latest AMRI Headlines from TheStreet
- Albany Molecular Research Inc. Stock Upgraded (AMRI) 09.26.12 | 05:09 am
- Stocks Under $5: Hidden Value in Healthcare
09.01.11 | 05:09 am - Applespeed Fund Goes Bargain Hunting 10.30.10 | 06:10 am
- Albany Molecular Files Allegra Patent Lawsuits 09.15.09 | 10:09 am
- Movers Roundup: Urban Outfitters, Hot Topic 05.07.09 | 02:05 pm
- Albany Molecular Shares Fall On 1Q Profit, Outlook 05.07.09 | 11:05 am
- Health Winners & Losers: Onyx 08.06.08 | 05:08 pm
- Monday's Winners & Losers: Yahoo! 05.05.08 | 04:05 pm
- Monday's Health Winners & Losers 05.05.08 | 02:05 pm
- Monday's Health Winners & Losers 02.11.08 | 04:02 pm
Press Releases for AMRI
- AMRI CFO To Present At The UBS Global Healthcare Conference - PR Newswire 05.15.13 | 08:05 am
- AMRI To Announce First Quarter Results - PR Newswire 04.24.13 | 08:04 am
- AMRI And Ono Broaden SMARTSOURCINGâ¿¢ Collaboration - PR Newswire 04.23.13 | 03:04 pm
- AMRI CEO To Present At The 12th Annual Needham Healthcare Conference - PR Newswire 04.23.13 | 08:04 am
- AMRI Promotes Takeshi Yura, Ph.D., To Vice President Of Discovery And Development Services, Asia - PR Newswire 02.25.13 | 08:02 am
- AMRI And Codexis Announce Technology Collaboration - PR Newswire 02.13.13 | 08:02 am
- AMRI Signs Agreement For Exclusive License Of Its Tubulin Inhibitor Program For Cancer - PR Newswire 02.11.13 | 08:02 am
- AMRI To Announce Fourth Quarter Results - PR Newswire 01.15.13 | 08:01 am
- AMRI Promotes Richard A. Saffee To Vice President And General Manager Of Large Scale Manufacturing - PR Newswire 01.08.13 | 08:01 am
- AMRI Extends Long Term Supply Relationship With GE Healthcare - PR Newswire 12.06.12 | 08:12 am
Partner Headlines for AMRI
- 5 Undervalued Healthcare Stocks That Analysts Love - Seeking Alpha 08.29.12 | 09:08 am
- Pre-Market Earnings Report for August 1, 2012 : AMT, ADP, AGN, AVP, GAS, AGP, BOKF, BAH, BCPC, ASCA, AMRI, ALVR - NASDAQ 07.31.12 | 08:07 pm
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 11.14.11 | 09:11 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 11.10.11 | 09:11 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.12.10 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 10.05.10 | 09:10 am
- UPDATE 1-Albany Molecular says facility gets warning letter - Reuters 08.20.10 | 06:08 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.06.10 | 09:08 am
